Company intelligence / Profile preview
Linnane Pharma
Swedenlinnanepharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Linnane Pharma, through its subsidiaries, has achieved clinical proof of concept for novel cancer therapeutics (Hamlet Pharma, Phase 1/2 bladder cancer trial) and for immunotherapy alternatives to antibiotics (SelectImmune Pharma, clinical validation in severe bladder pain syndrome). Additional projects are in earlier stages, backed by a strong patent portfolio[1][2].
- Therapeutic areas
- OncologyInfectious DiseasesImmunology
- Modalities
- Small moleculeSynthetic peptideImmunotherapyBiologic
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Hamlet BioPharma
Beyond the preview
Go deeper on Linnane Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Linnane Pharma.